Pfizer Inc (PFE) — 8-K Filings

8-K Filings (19)

• 8-K Filing — May 5, 2026
• 8-K Filing — Dec 16, 2025
• Pfizer Issues Multiple Note Series — Nov 21, 2025 Risk: low
  On November 18, 2025, Pfizer Inc. filed an 8-K report detailing the issuance of several series of notes. These include $1.000 Notes due 2027, $2.875 Notes due 2
• Pfizer Inc. Files 8-K Report — May 19, 2025 Risk: low
  On May 14, 2025, Pfizer Inc. filed an 8-K report detailing other events and financial statements. The filing does not disclose specific new material events or f
• Pfizer Inc. Files 8-K on Financials and Operations — Apr 29, 2025 Risk: low
  On April 29, 2025, Pfizer Inc. filed an 8-K report detailing results of operations and financial condition. The filing also covers cost associated with exit or
• Pfizer Inc. Files 8-K on Shareholder Votes — Apr 28, 2025 Risk: low
  Pfizer Inc. filed an 8-K on April 28, 2025, reporting on matters submitted to a vote of security holders as of April 24, 2025. The filing details the company's
• Pfizer Inc. Files 8-K on Financials — Feb 4, 2025 Risk: low
  On February 4, 2025, Pfizer Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and e
• Pfizer Inc. Files 8-K Report — Dec 17, 2024 Risk: low
  On December 17, 2024, Pfizer Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, as well as a Regulation FD Disclosure. N
• Pfizer Inc. Files 8-K on Financials — Oct 29, 2024 Risk: low
  On October 29, 2024, Pfizer Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on common stoc
• Pfizer Inc. Files 8-K: Board and Executive Compensation Updates — Oct 15, 2024 Risk: low
  On October 10, 2024, Pfizer Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes information on
• Pfizer Inc. Files 8-K: Financial Update — Jul 30, 2024 Risk: low
  On July 30, 2024, Pfizer Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and exhi
• Pfizer Announces Executive and Board Changes — Jul 26, 2024 Risk: medium
  On July 24, 2024, Pfizer Inc. announced changes in its executive leadership and board of directors. Dr. Mikael Dolsten will transition from his role as Chief Sc
• Pfizer Adjusts Executive Compensation Plans — Jul 10, 2024 Risk: low
  On July 9, 2024, Pfizer Inc. announced changes to its executive compensation program. The company's Compensation Committee of the Board of Directors approved am
• Pfizer Appoints New Directors, CAO Departs — Jul 1, 2024 Risk: low
  On June 27, 2024, Pfizer Inc. filed an 8-K report detailing the departure of its Chief Accounting Officer, Michael G. McLellan, effective June 28, 2024. The com
• Pfizer Reports Exit and Disposal Costs — May 22, 2024 Risk: medium
  On May 22, 2024, Pfizer Inc. filed an 8-K report detailing cost associated with exit or disposal activities. The filing does not specify any dollar amounts or s
• Pfizer Inc. Files 8-K with Financial Updates — May 1, 2024 Risk: low
  On May 1, 2024, Pfizer Inc. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibits, providing
• Pfizer Inc. Files 8-K on Shareholder Vote Matters — Apr 29, 2024 Risk: low
  On April 25, 2024, Pfizer Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing does not contain specific details
• Pfizer Updates Registered Securities on NYSE — Jan 30, 2024
  Pfizer Inc. filed an 8-K on January 30, 2024, to update its registered securities, specifically its Common Stock ($0.05 par value) and 1.000% Notes due 2027. Bo
• Pfizer Confirms NYSE Listing for Common Stock, 1.000% Notes Due 2027 — Jan 10, 2024
  Pfizer Inc. filed an 8-K on January 10, 2024, to update its registered securities. The filing confirms that both its Common Stock, with a $.05 par value, and it

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX